Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10234397rdf:typepubmed:Citationlld:pubmed
pubmed-article:10234397lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0002903lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0021925lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0442025lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0184661lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0040223lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0209337lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C1373204lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C1300559lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0750729lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:10234397lifeskim:mentionsumls-concept:C0439608lld:lifeskim
pubmed-article:10234397pubmed:issue3lld:pubmed
pubmed-article:10234397pubmed:dateCreated1999-6-24lld:pubmed
pubmed-article:10234397pubmed:abstractTextRocuronium is a non-depolarising neuromuscular blocking agent structurally related to vecuronium. The compound has a rapid onset and an intermediate duration of action. The rapid onset is of importance in patients at risk for pulmonary aspiration, for elective induction of anaesthesia slower onset properties generally are accepted. In this context, we asked whether the induction dose of rocuronium may be reduced to doses smaller than 2 x ED95 in situations in which slower onset properties may be acceptable.lld:pubmed
pubmed-article:10234397pubmed:languagegerlld:pubmed
pubmed-article:10234397pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10234397pubmed:citationSubsetIMlld:pubmed
pubmed-article:10234397pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10234397pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10234397pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10234397pubmed:statusMEDLINElld:pubmed
pubmed-article:10234397pubmed:monthMarlld:pubmed
pubmed-article:10234397pubmed:issn0003-2417lld:pubmed
pubmed-article:10234397pubmed:authorpubmed-author:ZiegenfussTTlld:pubmed
pubmed-article:10234397pubmed:authorpubmed-author:Fuchs-BuderTTlld:pubmed
pubmed-article:10234397pubmed:authorpubmed-author:SchlaichNNlld:pubmed
pubmed-article:10234397pubmed:issnTypePrintlld:pubmed
pubmed-article:10234397pubmed:volume48lld:pubmed
pubmed-article:10234397pubmed:ownerNLMlld:pubmed
pubmed-article:10234397pubmed:authorsCompleteYlld:pubmed
pubmed-article:10234397pubmed:pagination164-8lld:pubmed
pubmed-article:10234397pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:meshHeadingpubmed-meshheading:10234397...lld:pubmed
pubmed-article:10234397pubmed:year1999lld:pubmed
pubmed-article:10234397pubmed:articleTitle[Rocuronium for anesthesia induction in elective procedures. Time course of muscular blockade and intubation after administration of 2-compartment ED95 (0.6 mg/kg) and dose reduction (0.4 mg/kg)].lld:pubmed
pubmed-article:10234397pubmed:affiliationKlinik für Anästhesie und Intensivmedizin, Universitätskliniken des Saarlandes, Homburg/Saar.lld:pubmed
pubmed-article:10234397pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10234397pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10234397pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:10234397pubmed:publicationTypeRandomized Controlled Triallld:pubmed